Medicare Enrolled

Dr. Manmohan Gursahani, MD

Urology Physician · Fullerton, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1024 FERNDALE AVE, Fullerton, CA 92831
5592414513
In practice since 2006 (19 years)
NPI: 1720042336 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gursahani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gursahani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gursahani

Dr. Manmohan Gursahani is an urology physician in Fullerton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gursahani performed 1,266 Medicare services across 835 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gursahani received a total of $2,176 from 30 pharmaceutical and/or device companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gursahani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 49% volume in CA $2,176 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,266
Medicare services
Top 49% in CA for urology physician
835
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~67 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
434 $65 $199
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
388 $3 $6
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
325 $8 $110
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
71 $121 $363
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
35 $198 $380
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
13 $87 $281
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,176
Total received (2018-2024)
Avg $311/year across 7 years
Bottom 48% in CA for urology physician
30
Companies
106
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,176 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$409
2023
$314
2022
$317
2021
$108
2020
$122
2019
$568
2018
$338

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$135
Tolmar, Inc.
$84
Dendreon Pharmaceuticals LLC
$44
Endo USA, Inc.
$25
ACCORD HEALTHCARE, INC.
$25
Merck Sharp & Dohme LLC
$23
COLOPLAST CORP
$20
ABBVIE INC.
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
PROGENICS PHARMACEUTICALS, INC.
$15
Top 3 companies account for 64.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$661
Sumitomo Pharma America, Inc.
$175
AbbVie, Inc.
$142
Tolmar, Inc.
$139
Progenics Pharmaceuticals, Inc.
$138
PFIZER INC.
$92
ABBVIE INC.
$90
AbbVie Inc.
$88
Bayer Healthcare Pharmaceuticals Inc.
$71
Myovant Sciences Inc.
$61
Merck Sharp & Dohme LLC
$45
Dendreon Pharmaceuticals LLC
$44
Boston Scientific Corporation
$42
UROVANT SCIENCES INC
$36
Coloplast Corp
$29
AngioDynamics, Inc.
$28
Teleflex LLC
$27
Telix Pharmaceuticals
$25
Endo USA, Inc.
$25
ACCORD HEALTHCARE, INC.
$25
NeoTract Inc.
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
Curium US LLC
$22
Endo Pharmaceuticals Inc.
$21
COLOPLAST CORP
$20
UroGen Pharma, Inc.
$20
MEDIVATION FIELD SOLUTIONS LLC
$17
Mission Pharmacal Company
$17
Janssen Biotech, Inc.
$16
PROGENICS PHARMACEUTICALS, INC.
$15
Top 3 companies account for 44.9% of all-time payments
Associated products mentioned in payments ›
Altis · Androgel · BOTOX · CAMCEVI · EDEX · ELIGARD · ERLEADA · GEMTESA · ILLUCCIX · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · NANOKNIFE · Nubeqa · ORGOVYX · PROVENGE · PYLARIFY · Porges Coloplast · SOLYX · TOVIAZ · ULTRASOUND PROBE · Uribel · UroLift · UroLift System · XIAFLEX · XTANDI · Xtandi
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in Fullerton?
Compare urology physicians in the Fullerton area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
317
Per 100K population
10.0
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JUDE MEDICAL CENTER
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gursahani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gursahani experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Gursahani performed 434 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gursahani receive payments from pharmaceutical companies?
Yes. Dr. Gursahani received a total of $2,176 from 30 companies across 106 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gursahani's costs compare to other urology physicians in Fullerton?
Dr. Gursahani's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gursahani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →